Jordi Mata-Fink co-founded and leads Gate Bioscience, developing small molecules that prevent harmful extracellular proteins from being secreted. Previously at Flagship Pioneering, he helped launch Editas Medicine, Rubius Therapeutics and Generate Biomedicines.
Jordi Mata-Fink co-founded and leads Gate Bioscience, developing small molecules that prevent harmful extracellular proteins from being secreted. Previously at Flagship Pioneering, he helped launch Editas Medicine, Rubius Therapeutics and Generate Biomedicines.
Career
CEO at Gate Bioscience from 2021-07 to Present